Cagent Vascular Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 78

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $41M

  • Investors
  • 11

Cagent Vascular General Information

Description

Developer of an intravascular technology designed to treat diseased peripheral arteries. The company's technology is a minimally invasive device for vessel dilatation in cardiovascular disease interventions with multiple longitudinal lines of interrupted micro-serrations used for arterial expansion along those lines, enabling healthcare providers to improve the lives of patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 150 Strafford Avenue
  • Suite 315
  • Wayne, PA 19087
  • United States
+1 (610)
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Drug Discovery
Biotechnology
Vertical(s)
Corporate Office
  • 150 Strafford Avenue
  • Suite 315
  • Wayne, PA 19087
  • United States
+1 (610)

Cagent Vascular Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cagent Vascular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series D) 18-May-2026 $41M Completed Generating Revenue
8. Debt - General 15-Jan-2026 Completed Generating Revenue
7. Later Stage VC 20-Feb-2025 Completed Generating Revenue
6. Later Stage VC (Series C) 30-Jan-2024 Completed Generating Revenue
5. Later Stage VC 23-Jun-2021 Completed Generating Revenue
4. Debt - PPP 29-Apr-2020 Completed Generating Revenue
3. Early Stage VC (Series B) 14-May-2018 Completed Generating Revenue
2. Early Stage VC (Series A) 22-Jun-2016 $750K $800K Completed Startup
1. Angel (individual) 23-Jun-2014 $50K $50K Completed Startup
To view Cagent Vascular’s complete valuation and funding history, request access »

Cagent Vascular Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C-2
Series C-1
Series B 28,527,570 $0.000010 $1.25 $1.25 1x $1.25 4.51%
Series A 7,045,716 $0.000010 $1 $1 1x $1 1.11%
To view Cagent Vascular’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cagent Vascular Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an intravascular technology designed to treat diseased peripheral arteries. The company's technology is a m
Surgical Devices
Wayne, PA
78 As of 2025

Shanghai, China
 

San Leandro, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cagent Vascular Competitors (27)

One of Cagent Vascular’s 27 competitors is Wallaby Medical, a Venture Capital-Backed company based in Shanghai, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Wallaby Medical Venture Capital-Backed Shanghai, China
Mercator MedSystems Venture Capital-Backed San Leandro, CA
Arsenal Medical Venture Capital-Backed Waltham, MA
Vesper Medical Formerly VC-backed Wayne, PA
Elixir Medical Venture Capital-Backed Milpitas, CA
You’re viewing 5 of 27 competitors. Get the full list »

Cagent Vascular Patents

Cagent Vascular Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260345180-A1 Pulse enhanced balloon catheter and methods of use Pending 30-Apr-2025
US-20260345181-A1 Pulse enhanced balloon catheter and methods of use Pending 30-Apr-2025
US-20260345182-A1 Pulse enhanced balloon catheter and methods of use Pending 30-Apr-2025
US-20260345183-A1 Pulse enhanced balloon catheter and methods of use Pending 30-Apr-2025
US-20260345184-A1 Pulse enhanced balloon catheter and methods of use Pending 30-Apr-2025 A61B17/2202
To view Cagent Vascular’s complete patent history, request access »

Cagent Vascular Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cagent Vascular Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Astoria Health Investors Venture Capital Minority
BF Belmont Family Office Minority
Trinity Capital (Phoenix) Asset Manager Minority
Blue Ridge Medical. Corporation Minority
The FSB Companies PE/Buyout Minority
You’re viewing 5 of 11 investors. Get the full list »

Cagent Vascular FAQs

  • When was Cagent Vascular founded?

    Cagent Vascular was founded in 2014.

  • Where is Cagent Vascular headquartered?

    Cagent Vascular is headquartered in Wayne, PA.

  • What is the size of Cagent Vascular?

    Cagent Vascular has 78 total employees.

  • What industry is Cagent Vascular in?

    Cagent Vascular’s primary industry is Surgical Devices.

  • Is Cagent Vascular a private or public company?

    Cagent Vascular is a Private company.

  • What is the current valuation of Cagent Vascular?

    The current valuation of Cagent Vascular is .

  • What is Cagent Vascular’s current revenue?

    The current revenue for Cagent Vascular is .

  • How much funding has Cagent Vascular raised over time?

    Cagent Vascular has raised $118M.

  • Who are Cagent Vascular’s investors?

    Astoria Health Investors, BF Belmont, Trinity Capital (Phoenix), Blue Ridge Medical., and The FSB Companies are 5 of 11 investors who have invested in Cagent Vascular.

  • Who are Cagent Vascular’s competitors?

    Wallaby Medical, Mercator MedSystems, Arsenal Medical, Vesper Medical, and Elixir Medical are some of the 27 competitors of Cagent Vascular.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process